GenMont Biotech (Taiwan) Analysis
| 3164 Stock | TWD 20.40 0.10 0.49% |
GenMont Biotech is fairly valued with Real Value of 21.13 and Hype Value of 20.4. The main objective of GenMont Biotech stock analysis is to determine its intrinsic value, which is an estimate of what GenMont Biotech is worth, separate from its market price. There are two main types of GenMont Biotech's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect GenMont Biotech's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of GenMont Biotech's stock to identify patterns and trends that may indicate its future price movements.
The GenMont Biotech stock is traded in Taiwan on Taiwan Stock Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. GenMont Biotech is usually not traded on National Day of the Republic of China. GenMont Stock trading window is adjusted to Asia/Shanghai timezone.
GenMont |
GenMont Stock Analysis Notes
About 37.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.58. In the past many companies with similar price-to-book ratios have beat the market. GenMont Biotech last dividend was issued on the 24th of June 2022. The entity had 110:100 split on the 15th of June 2010. GenMont Biotech Incorporation engages in the research, development, and production of functional probiotics in Taiwan. The company was founded in 2000 and is based in Tainan, Taiwan. GENMONT BIOTECH operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange. For more info on GenMont Biotech please contact the company at 886 8 0080 0980 or go to https://www.genmont.com.tw.GenMont Biotech Investment Alerts
| GenMont Biotech generated a negative expected return over the last 90 days | |
| About 37.0% of the company shares are owned by insiders or employees |
GenMont Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GenMont Biotech's market, we take the total number of its shares issued and multiply it by GenMont Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.GenMont Profitablity
GenMont Biotech's profitability indicators refer to fundamental financial ratios that showcase GenMont Biotech's ability to generate income relative to its revenue or operating costs. If, let's say, GenMont Biotech is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, GenMont Biotech's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of GenMont Biotech's profitability requires more research than a typical breakdown of GenMont Biotech's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.2 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.2. Technical Drivers
As of the 27th of November, GenMont Biotech retains the Standard Deviation of 0.9699, risk adjusted performance of (0.13), and Market Risk Adjusted Performance of (15.88). GenMont Biotech technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out GenMont Biotech standard deviation, information ratio, maximum drawdown, as well as the relationship between the variance and treynor ratio to decide if GenMont Biotech is priced fairly, providing market reflects its last-minute price of 20.4 per share.GenMont Biotech Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. GenMont Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for GenMont Biotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
GenMont Biotech Outstanding Bonds
GenMont Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GenMont Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GenMont bonds can be classified according to their maturity, which is the date when GenMont Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
GenMont Biotech Predictive Daily Indicators
GenMont Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of GenMont Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 761.82 | |||
| Daily Balance Of Power | 0.25 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 20.45 | |||
| Day Typical Price | 20.43 | |||
| Period Momentum Indicator | 0.1 |
GenMont Biotech Forecast Models
GenMont Biotech's time-series forecasting models are one of many GenMont Biotech's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary GenMont Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About GenMont Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how GenMont Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling GenMont shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as GenMont Biotech. By using and applying GenMont Stock analysis, traders can create a robust methodology for identifying GenMont entry and exit points for their positions.
GenMont Biotech Incorporation engages in the research, development, and production of functional probiotics in Taiwan. The company was founded in 2000 and is based in Tainan, Taiwan. GENMONT BIOTECH operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding GenMont Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
Additional Tools for GenMont Stock Analysis
When running GenMont Biotech's price analysis, check to measure GenMont Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GenMont Biotech is operating at the current time. Most of GenMont Biotech's value examination focuses on studying past and present price action to predict the probability of GenMont Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GenMont Biotech's price. Additionally, you may evaluate how the addition of GenMont Biotech to your portfolios can decrease your overall portfolio volatility.